Table 2.
NOS3 894G>T | SB patients (%) | Pediatric controls (%) | OR (95%CI) |
---|---|---|---|
GG | 39 (41.1) | 111 (53.6) | 1a |
GT | 46 (48.4) | 80 (38.6) | 1.64 (0.98–2.74) |
TT | 10 (10.5) | 16 (7.7) | 1.78 (0.75–4.25) |
aReference group
NOS3 894G>T | SB patients (%) | Pediatric controls (%) | OR (95%CI) |
---|---|---|---|
GG | 39 (41.1) | 111 (53.6) | 1a |
GT | 46 (48.4) | 80 (38.6) | 1.64 (0.98–2.74) |
TT | 10 (10.5) | 16 (7.7) | 1.78 (0.75–4.25) |
aReference group